NEWS HIGHLIGHTS
Published Studies Related to Florinef (Fludrocortisone)
Biological and hemodynamic effects of low doses of fludrocortisone and hydrocortisone, alone or in combination, in healthy volunteers with hypoaldosteronism. [2010.08]
Low doses of hydrocortisone (HC) and fludrocortisone (FC) administered together improve the prognosis after septic shock; however, there continues to be disagreement about the utility of FC for this indication. The biological and hemodynamic effects of HC (50 mg intravenously) and FC (50 microg orally) were assessed in 12 healthy male volunteers with saline-induced hypoaldosteronism in a placebo-controlled, randomized, double-blind, crossover study performed according to a 2 x 2 factorial design...
Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease. [2007.08.15]
There is limited evidence for the treatment of orthostatic hypotension in idiopathic Parkinson's disease. The objective of this study was to determine the efficacy of three treatments (nonpharmacological therapy, fludrocortisone, and domperidone)... There was a trend towards reduced blood pressure drop on tilt table testing, with domperidone having a greater effect.
Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease. [2007.06.07]
There is limited evidence for the treatment of orthostatic hypotension in idiopathic Parkinson's disease. The objective of this study was to determine the efficacy of three treatments (nonpharmacological therapy, fludrocortisone, and domperidone)... There was a trend towards reduced blood pressure drop on tilt table testing, with domperidone having a greater effect.
The Second Prevention of Syncope Trial (POST II)--a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design. [2006.06]
BACKGROUND: Neurally mediated syncope is a common and frequently distressing problem. It is associated with a poor quality of life, which improves when the frequency of syncope is reduced...
A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients. [2006.05]
BACKGROUND: Previous small uncontrolled studies suggested that fludrocortisone may significantly decrease serum potassium concentrations in hemodialysis patients, possibly through enhancement of colonic potassium secretion. The aim of this study is to evaluate the effect of oral fludrocortisone on serum potassium concentrations in hyperkalemic hemodialysis patients in an open-label randomized controlled trial... CONCLUSION: Administering fludrocortisone to hyperkalemic hemodialysis patients is safe and well tolerated, but does not achieve clinically important decreases in serum potassium levels.
Clinical Trials Related to Florinef (Fludrocortisone)
Fludrocortisone and Information Processing in Healthy Volunteers [Recruiting]
Stimulating the mineralocorticoid receptor (MR) may restore a disturbed balance as seen in
depression. In this double-blind, randomized, placebo-controlled trial the investigators
will test the effects of a single dose (500mg) fludrocortisone, an MR-agonist, on the
information processing in healthy female volunteers (N = 2x20).
The investigators want to investigate whether the acute administration of fludrocortisone
(FC) in healthy females enhances the appraisal of emotional information related to
depression, hypothesizing that:
- FC relative to placebo selectively improves the recognition of happy and fearful faces:
resulting in more correct responses and faster RTs.
- FC induces a bias towards more positive self-description and an improved memory for
positive information.
Female participants were selected because the haplotype MRI180V is related to depression
vulnerability in women, not in men. If the effects of fludrocortisone are comparable to the
effects of antidepressants on the same tests and the same population, it might be a first
indication that fludrocortisone may function as an antidepressant.
Fludrocortisone's Test in Salt Sensitivity [Recruiting]
Fludrocortisone for Sudden Hearing Loss [Recruiting]
The standard of care treatment of sudden hearing loss uses a type of steroid called
glucocorticoid. Examples of glucocorticoids are prednisone, methylprednisolone and
dexamethasone. Not everybody recovers hearing with glucocorticoid treatment. Fludrocortisone
is a different type of steroid called mineralocorticoid. Unlike glucocorticoids, which work
by reducing inflammation, mineralocorticoids work by changing salt and fluid balance. In
animal studies, fludrocortisone is at least as effective as glucocorticoid in preserving
hearing. Fludrocortisone is not approved for the treatment of sudden hearing loss. The
purpose of this study is to test whether fludrocortisone can treat sudden hearing loss.
Effects of Fludrocortisone and Hydrocortisone in Healthy Volunteers With Aldosterone Induced Suppression [Recruiting]
Septic shock (associated with relative adrenal insufficiency) is characterized by decreased
arterial responsiveness to catecholamines. The association of hydrocortisone and
fludrocortisone has demonstrated an improvement in survival in septic shock patients. If
hydrocortisone has shown to increase vascular responsiveness, the role of fludrocortisone
remains to be elucidated. The purpose of our study is to investigate the effect of a
physiological dose of fludrocortisone and/or hydrocortisone on phenylephrine-mean arterial
pressure dose-response relationship in healthy volunteers with aldosterone suppression
induced by intravenous sodium loading.
Corticosteroid Therapy for Glucocorticoid Insufficiency Related to Traumatic Brain Injury [Recruiting]
Traumatic brained injured (TBI) patients frequently suffered from glucocorticoid
insufficiency that is associated with a raise in the rate of pneumonia.
In a placebo-controlled, multi-center, double-blinded trial, treatment of glucocorticoid
insufficiency (hydrocortisone associated with fludrocortisone) will be assessed for
prevention of post trauma pneumonia in a population of severe TBI patients.
|
